1. Home
  2. SNPX vs SCNI Comparison

SNPX vs SCNI Comparison

Compare SNPX & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPX
    SELLHOLDBUYas of 2 days ago
  • SCNI
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • SNPX 2012
  • SCNI 2003
  • Country
  • SNPX United States
  • SCNI Israel
  • Employees
  • SNPX N/A
  • SCNI N/A
  • Industry
  • SNPX Medicinal Chemicals and Botanical Products
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SNPX Health Care
  • SCNI Health Care
  • Exchange
  • SNPX Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • SNPX 3.7M
  • SCNI 3.5M
  • IPO Year
  • SNPX N/A
  • SCNI N/A
  • Fundamental
  • Price
  • SNPX $3.07
  • SCNI $3.40
  • Analyst Decision
  • SNPX Strong Buy
  • SCNI
  • Analyst Count
  • SNPX 1
  • SCNI 0
  • Target Price
  • SNPX $14.00
  • SCNI N/A
  • AVG Volume (30 Days)
  • SNPX 18.6K
  • SCNI 11.8K
  • Earning Date
  • SNPX 11-12-2024
  • SCNI 11-22-2024
  • Dividend Yield
  • SNPX N/A
  • SCNI N/A
  • EPS Growth
  • SNPX N/A
  • SCNI N/A
  • EPS
  • SNPX N/A
  • SCNI 8.20
  • Revenue
  • SNPX N/A
  • SCNI $452,000.00
  • Revenue This Year
  • SNPX N/A
  • SCNI N/A
  • Revenue Next Year
  • SNPX N/A
  • SCNI N/A
  • P/E Ratio
  • SNPX N/A
  • SCNI $0.41
  • Revenue Growth
  • SNPX N/A
  • SCNI N/A
  • 52 Week Low
  • SNPX $2.32
  • SCNI $2.23
  • 52 Week High
  • SNPX $8.78
  • SCNI $8.92
  • Technical
  • Relative Strength Index (RSI)
  • SNPX 57.58
  • SCNI 51.71
  • Support Level
  • SNPX $2.52
  • SCNI $3.20
  • Resistance Level
  • SNPX $2.80
  • SCNI $3.55
  • Average True Range (ATR)
  • SNPX 0.21
  • SCNI 0.17
  • MACD
  • SNPX 0.00
  • SCNI 0.01
  • Stochastic Oscillator
  • SNPX 87.30
  • SCNI 57.14

Stock Price Comparison Chart: SNPX vs SCNI

SNPX
SCNI
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober051015202530354045505560SNPX VS SCNI

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use